Xbiotech, Inc.
Clinical trials sponsored by Xbiotech, Inc., explained in plain language.
-
New antibody shot shows promise for Tough-to-Treat arthritis
Disease control Not yet recruitingThis Phase 2 trial tests whether adding a lab-made antibody called natrunix to standard methotrexate treatment helps people with moderate to severe rheumatoid arthritis who haven't improved enough on methotrexate alone. About 108 participants will receive weekly shots of either n…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug aims to ease back pain and stiffness for arthritis patients
Symptom relief Not yet recruitingThis study tests whether the drug vilamakitug can reduce symptoms of axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. About 150 adults with active disease will receive either the drug or a placebo. The main goal is to see if more people get at lea…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC